Teladoc Health (TDOC) Common Equity (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Common Equity data on file, last reported at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 6.36% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (down 6.36% YoY), and the FY2025 full-year result was $1.4 billion, down 7.07% from the prior year.
• Common Equity slipped to $1.3 billion in Q1 2026, from $1.4 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $9.1 billion in Q1 2022 to a low of $1.3 billion in Q1 2026.
• A 5-year average of $2.7 billion and a median of $2.3 billion in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity tumbled 85.62% in 2022 and gained 0.79% in 2023, its largest moves.
• Tracing TDOC's Common Equity over 5 years: stood at $2.3 billion in 2022, then grew by 0.79% to $2.3 billion in 2023, then sank by 35.9% to $1.5 billion in 2024, then dropped by 7.07% to $1.4 billion in 2025, then declined by 3.56% to $1.3 billion in 2026.
• Business Quant data shows TDOC's Common Equity at $1.3 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.4 billion in Q3 2025.